The startup process is an important part of the clinical trial and delays can have a huge impact on the cost of a study and ultimately the cost to develop a drug. At Medcare Pharma Research, we have an efficient start up process. From site selection to study activation, it takes average of 6 weeks. We use central IRB to expedite start-up process. In addition, contract, budget, and regulatory all can be done in parallel.